Advagene Biopharma Co (ROCO:6709) EV-to-EBITDA : -14.18 (As of May. 25, 2024)

Advagene Biopharma Co EV-to-EBITDA Chart

Advagene Biopharma Co Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial										-25.33	-	-12.96	-	-15.91

Competitive Comparison of Advagene Biopharma Co's EV-to-EBITDA

For the Biotechnology subindustry, Advagene Biopharma Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advagene Biopharma Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advagene Biopharma Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Advagene Biopharma Co's EV-to-EBITDA falls into.

Advagene Biopharma Co EV-to-EBITDA Calculation

Advagene Biopharma Co's EV-to-EBITDA for today is calculated as:

Advagene Biopharma Co's current Enterprise Value is NT$1,135.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advagene Biopharma Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-80.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advagene Biopharma Co  (ROCO:6709) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Advagene Biopharma Co's PE Ratio for today is calculated as:

Advagene Biopharma Co's share price for today is NT$23.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Advagene Biopharma Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1.830.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Advagene Biopharma Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Advagene Biopharma Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Advagene Biopharma Co (ROCO:6709) Business Description